Li P F, Liu G T
Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050.
Yao Xue Xue Bao. 1997 Sep;32(9):663-8.
Many carcinogens must be first transformed into electrophilic ultimate carcinogens via metabolic activation in liver microsomes before covalent binding to nucleophilic center of DNA. SY-640 is a synthetic compound with hepatoprotective activity. Results of the present study indicate that the covalent binding of 3H-benzo(a)pyrine to mouse hepatocyte nuclear DNA in vitro and in vivo was markedly inhibited by SY-640. Further studies found that the liver microsomal cytochrome P-450 content and aminopyrine demethylase activity were significantly increased in mice treated with SY-640 (150 mg.kg-1 p.o.) once daily for three days, while the hepatic microsomal aminopyrine demethylase activity was obviously inhibited two hours after oral administration of SY-640 150 mg.kg-1 in mice. The aminopyrine demethylase activity of liver microsomes from normal, PB- and 3-MC-treated mice was also significantly inhibited by the addition of SY-640 in vitro. When SY-640 was incubated with NADPH-reduced mouse liver microsomes, a metabolic-intermediate(MI) complex at 457 nm was formed. The effects of SY-640 on cytochrome P-450 and its formation of MI complex with cytochrome P-450 may partially explain why SY-640 could inhibit covalent-binding of BP to mouse hepatocyte DNA in vitro.
许多致癌物在与DNA的亲核中心共价结合之前,必须先通过肝脏微粒体中的代谢激活转化为亲电最终致癌物。SY-640是一种具有肝保护活性的合成化合物。本研究结果表明,SY-640在体外和体内均能显著抑制3H-苯并(a)芘与小鼠肝细胞核DNA的共价结合。进一步研究发现,连续三天每天一次给小鼠口服SY-640(150 mg·kg-1)后,小鼠肝脏微粒体细胞色素P-450含量和氨基比林脱甲基酶活性显著增加,而给小鼠口服150 mg·kg-1 SY-640两小时后,肝脏微粒体氨基比林脱甲基酶活性明显受到抑制。体外添加SY-640也能显著抑制正常、经苯巴比妥和3-甲基胆蒽处理的小鼠肝脏微粒体的氨基比林脱甲基酶活性。当SY-640与NADPH还原的小鼠肝脏微粒体孵育时,在457 nm处形成了一种代谢中间体(MI)复合物。SY-640对细胞色素P-450的影响及其与细胞色素P-450形成MI复合物的过程可能部分解释了SY-640在体外能够抑制BP与小鼠肝细胞DNA共价结合的原因。